BK Technologies Corp. (BKTI)
AMEXInformation TechnologyCommunication EquipmentSnapshot 2026-09-09
$72.87+0.66%
Close 2026-09-09 · 1-day change
AMEXInformation TechnologyCommunication EquipmentSnapshot 2026-09-09
Intact: The reason to own it still holds.
BK Technologies aims for $90M revenue and 50% gross margin in 2026. Profit per share is expected at $3.55. The company has a cheap valuation with a PE of 21 versus peers at 71.5. FCC approval for new products could boost sales.
Revenue growth may slow as recent quarterly revenue lags needed pace. Gross margin progress is unclear despite targets. The stock is under pressure with a 16% drawdown and recent selloff.
The price is about 32% below our fair value near $121. Analysts expect 11% revenue growth. The market prices in moderate growth but recent selloff reflects some caution.
Breaks if: EPS falls below $3.20 in FY26
Maintain and expand gross margin to above 50% in 2026 through favorable product mix and operational discipline.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a stable growth opportunity with a focus on achieving specific revenue and margin targets. The current thesis state indicates that the company is on track with its goals, despite some near-term risks.
The market appears to have priced in a low level of fragility, reflecting a cheap valuation compared to peers. There is an expectations gap, suggesting that the market may not fully anticipate the company's potential for growth.
Management is focused on achieving $90 million in revenue and maintaining a gross margin of over 50%. Recent financial performance has been neutral, but the company has shown improvement in quality and momentum, which supports its growth trajectory.
The long-term thesis hinges on management's ability to meet its revenue and margin targets, as well as external factors like Federal Reserve rate changes and the performance of key sector players. Any guidance cuts could negatively impact sentiment.
The most important moves since the prior daily snapshot.
Mixed, the news cuts both ways. The company reported Q2 2026 revenue of $23.4 million, up 10.6% year-over-year. This indicates strong top-line growth and improved profitability. However, there are market concerns as shares fell despite the earnings beat. This suggests uncertainty about sustaining growth and achieving the $90 million revenue target for 2026.
as of 2026-09-09
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated as a priority in 3 of last 3 quarters. Gross margin improved from 47.2% in first half 2025 to 51.8% in first half 2026, exceeding the 50% target. Management consistently reiterated the 50%+ gross margin goal for 2026, indicating delivery on margin expansion.
“Gross margin reaches 51.9%, expanding by 445 basis points compared to 2Q25.”
“Gross margin expanded by over 480 basis points to 51.8%.”
“Reiterating full year 2026 targets: gross margin of +50%.”
Breaks if: FCC approval delayed beyond 2026
Breaks if: gross margin falls below 45% in FY26
Maintain and expand gross margin to above 50% in 2026 through favorable product mix and operational discipline.
Stated as a priority in 3 of last 3 quarters. Gross margin improved from 47.2% in first half 2025 to 51.8% in first half 2026, exceeding the 50% target. Management consistently reiterated the 50%+ gross margin goal for 2026, indicating delivery on margin expansion.
“Gross margin reaches 51.9%, expanding by 445 basis points compared to 2Q25.”
“Gross margin expanded by over 480 basis points to 51.8%.”
“Reiterating full year 2026 targets: gross margin of +50%.”
Breaks if: annual revenue falls below $80 million in FY26
Overall, BKTI's fundamentals are stable, but they face elevated risks that could affect performance. Not investment advice.